Stableford Capital Ii LLC Edwards Lifesciences Corp Transaction History

Stableford Capital Ii LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 23, 2024	BUY	$84.3 - $94.31 $13,403 - $14,995	159 Added 2.67%	6,104 $563,000
Q1 2024 Apr 09, 2024	SELL	$72.54 - $95.56 $2,538 - $3,344	-35 Reduced 0.59%	5,945 $568,000
Q4 2023 Jan 12, 2024	BUY	$61.71 - $77.76 $9,565 - $12,052	155 Added 2.66%	5,980 $455,000
Q3 2023 Oct 30, 2023	BUY	$69.28 - $93.38 $69 - $93	1 Added 0.02%	5,825 $403,000
Q2 2023 Aug 11, 2023	BUY	$81.41 - $94.33 $474,131 - $549,377	5,824 New	5,824 $549,000
Q4 2022 Jan 10, 2023	BUY	$68.3 - $87.44 $326,883 - $418,487	4,786 New	4,786 $365 Million

1,351

455M

9.76M

3.92M

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $41.9B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

Get notified when there are updates to the investment portfolio of Stableford Capital Ii LLC, based on Form 13F filings with the SEC.

Stay updated on Stableford Capital Ii LLC with notifications on news.